ALS Investment Fund
Overview
A patient-led and patient-centric venture philanthropy fund with a single focus on investing in companies developing therapeutics and diagnostics for Amyotrophic Lateral Sclerosis (ALS). It was founded by ALS patients for ALS patients, and all returns on investments are re-invested to support further research and development.
Portfolio Companies
8
Website
alsinvestmentfund.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Amylyx Pharmaceuticals | Apr 2020 | Convertible Debt | Co-investor |
| Verge Labs | Dec 2021 | Series B | Co-investor |
| Bloom Science | Dec 2021 | Series A | Lead |
| Emulate, Inc. | Aug 2019 | Series D | Co-investor |
| QurAlis | Mar 2023 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is ALS Investment Fund based?
ALS Investment Fund is headquartered in Amsterdam, North Holland, Netherlands.
When was ALS Investment Fund founded?
Founding year information for ALS Investment Fund is not publicly available.
How many portfolio companies does ALS Investment Fund have?
ALS Investment Fund has 8 portfolio companies in Caplight's dataset.
What are some companies in ALS Investment Fund's portfolio?
Portfolio companies visible on Caplight include Amylyx Pharmaceuticals, Verge Labs, Bloom Science, Emulate, Inc., QurAlis.
What was ALS Investment Fund's most recent investment shown here?
ALS Investment Fund's most recent investment in this portfolio sample was in QurAlis in 2023.
What sectors does ALS Investment Fund focus on?
ALS Investment Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does ALS Investment Fund focus on?
ALS Investment Fund typically invests at the MultiStage stage.